Guang Li-KY (6431) Corrects Q1 2026 IFRS iXBRL Filing Regarding Investee Information

Announcement Date: May 16, 2026 Statement Date: May 15, 2026 Statement Time: 193918 Company Code: 6431 Company Name: Guang Li-KY Subject: Correction of the company's Q1 2026 IFRSs iXBRL announcement information Compliance Clause: Clause 51 Date of Fact Occurrence: May 15, 2026 Explanation: 1. Date of Fact Occurrence: 115/05/15 2. Company Name: Guang Li Biotechnology Holdings Co., Ltd. 3. Relationship with Company (Enter 'Parent Company' or 'Subsidiary'): Parent Company 4. Proportion of Mutual Shareholding: Not applicable 5. Reason for Occurrence: Correction of the company's Q1 2026 IFRSs iXBRL announcement information 6. Item/Report Name Corrected: "Investee Company Name, Location, etc. Related Information" / IFRSs iXBRL Report 7. Original Amount/Content/Page Number: No such situation / Not required to disclose 8. Corrected Amount/Content/Page Number: IFRSs iXBRL "Investee Company Name, Location, etc. Related Information" Investing Company: Parent Company / Investee Company: Novel Idea Co., Ltd. Region Code: 132 / Location: Mauritius Main Business Item: Holding Company Original Investment Amount - End of Current Period: $188,771 / End of Last Year: $185,437 Shareholding Status at End of Period - Number of Shares: 5,900 thousand shares Shareholding Status at End of Period - Ratio: 100% Shareholding Status at End of Period - Book Value: ($368) Investee Company's Profit/Loss for the Current Period: ($151) Investment Gain/Loss Recognized in Current Period: ($151) ----------------------------------------------------------- IFRSs iXBRL "Investee Company Name, Location, etc. Related Information" Investing Company: Parent Company / Investee Company: Taiwan Guang Li Industrial Co., Ltd. Region Code: 0 / Location: Taiwan Main Business Item: Health Management Business Original Investment Amount - End of Current Period: $156,186 / End of Last Year: $126,186 Shareholding Status at End of Period - Number of Shares: 15,619 thousand shares Shareholding Status at End of Period - Ratio: 100% Shareholding Status at End of Period - Book Value: $33,680 Investee Company's Profit/Loss for the Current Period: ($7,200) Investment Gain/Loss Recognized in Current Period: ($7,200) ----------------------------------------------------------- IFRSs iXBRL "Investee Company Name, Location, etc. Related Information" Investing Company: Parent Company / Investee Company: Alliance Capital Investment Management Inc. Region Code: 226 / Location: British Virgin Islands Main Business Item: Holding Company Original Investment Amount - End of Current Period: $705,879 / End of Last Year: $695,382 Shareholding Status at End of Period - Number of Shares: 23 thousand shares Shareholding Status at End of Period - Ratio: 100% Shareholding Status at End of Period - Book Value: $303,271 Investee Company's Profit/Loss for the Current Period: ($20,906) Investment Gain/Loss Recognized in Current Period: ($25,736) Remarks: Note 3 ----------------------------------------------------------- IFRSs iXBRL "Investee Company Name, Location, etc. Related Information" Investing Company: Parent Company / Investee Company: Chen Li Biotechnology Co., Ltd. Region Code: 0 / Location: Taiwan Main Business Item: Cosmetics, Skincare, Health Product Trading Business Original Investment Amount - End of Current Period: $20,000 / End of Last Year: $20,000 Shareholding Status at End of Period - Number of Shares: 2,000 thousand shares Shareholding Status at End of Period - Ratio: 100% Shareholding Status at End of Period - Book Value: $19,550 Investee Company's Profit/Loss for the Current Period: 572 Investment Gain/Loss Recognized in Current Period: 572 ----------------------------------------------------------- IFRSs iXBRL "Investee Company Name, Location, etc. Related Information" Investing Company: Parent Company / Investee Company: Suan Li Intelligent Co., Ltd. Region Code: 0 / Location: Taiwan Main Business Item: Computer AI Hardware Sales and Information Processing Services Original Investment Amount - End of Current Period: $10,000 / End of Last Year: $10,000 Shareholding Status at End of Period - Number of Shares: 1,000 thousand shares Shareholding Status at End of Period - Ratio: 100% Shareholding Status at End of Period - Book Value: $9,498 Investee Company's Profit/Loss for the Current Period: ($275) Investment Gain/Loss Recognized in Current Period: ($275) ----------------------------------------------------------- IFRSs iXBRL "Investee Company Name, Location, etc. Related Information" Investing Company: Parent Company / Investee Company: Chen Yao Medical Management Consulting Co., Ltd. Region Code: 0 / Location: Taiwan Main Business Item: Health Consulting Services and Health Product Trading Business Original Investment Amount - End of Current Period: $10,000 / End of Last Year: $10,000 Shareholding Status at End of Period - Number of Shares: 1,000 thousand shares Shareholding Status at End of Period - Ratio: 100% Shareholding Status at End of Period - Book Value: $9,506 Investee Company's Profit/Loss for the Current Period: ($257) Investment Gain/Loss Recognized in Current Period: ($257) ----------------------------------------------------------- IFRSs iXBRL "Investee Company Name, Location, etc. Related Information" Investing Company: Parent Company / Investee Company: Chen Li International Co., Ltd. Original Investment Amount - End of Current Period: $7,000 / End of Last Year: $7,000 Shareholding Status at End of Period - Number of Shares: 700 thousand shares Shareholding Status at End of Period - Ratio: 70% Shareholding Status at End of Period - Book Value: $8,016 Investee Company's Profit/Loss for the Current Period: 1,994 Investment Gain/Loss Recognized in Current Period: 1,396 9. Countermeasures: Re-upload public information to the observatory after correction. 10. Other Matters to be Noted: None.